ESBLs-drug resistance phenotype of Escherichia coli and level of dissemination of research.docVIP

 PAGE \* MERGEFORMAT 2 ESBLs-drug resistance phenotype of Escherichia coli and level of dissemination of research [Abstract] Objective No. 1 People’s Hospital of Kunming in clinical isolates of Escherichia coli extended-spectrum β  ultra-lactamases (extended spectrum β  lactamases, ESBLs) of the resistance phenotype and level of dissemination of. Methods in January 2005 ~ December 1st People’s Hospital of Kunming, the 197 clinical isolates of Escherichia coli by phenotypic confirmatory test detected ESBLs, with Kirby  Bauer agar diffusion method to do the drug sensitivity test; with the understanding of ESBLs-bonding test gene is located in plasmids, and zygote to KB France ESBLs phenotypic drug susceptibility testing and confirmation. Results 197 producing ESBLs were detected E. coli bacteria 104, and the detection rate of 52.79%. Specimens in various strains producing ESBLs in the fiberoptic bronchoscope (bronchofibroscope, BF) brush the film separation rate was the highest (75%), the subjects do not look at samples of Endocrinology separation of Escherichia coli producing ESBLs highest rate (78.57%) . In addition to imipenem and amikacin, the ESBLs producing strains of other 15 kinds of antimicrobial agents was significantly higher than that of non-ESBLs producing strains (P